Richard Friedman

Chairman & CEO, BioScrip

Professional Overview
Richard Friedman is an experienced healthcare executive serving as the Chairman and Chief Executive Officer of BioScrip, a leading national provider of infusion and home care management solutions. With extensive expertise in the pharmaceutical and home healthcare industries, Friedman leverages his strategic vision and operational leadership to drive growth and innovation at BioScrip.

Experience Summary

Current Role
As Chairman and CEO of BioScrip, Friedman is responsible for setting the overall strategic direction of the company and overseeing all aspects of its operations. Under his leadership, BioScrip has strengthened its market position, expanded its service offerings, and improved financial performance. Friedman has been instrumental in guiding the company through significant regulatory changes and industry consolidation, positioning BioScrip as a trusted partner for patients, healthcare providers, and payers.

Career Progression
Prior to joining BioScrip, Friedman held various executive roles at leading healthcare organizations, including serving as the President and Chief Operating Officer of Coram, a national provider of infusion and specialty pharmacy services. He has a proven track record of driving business transformation, improving operational efficiency, and delivering superior patient outcomes.

Academic Background
Friedman holds a Bachelor of Arts degree from the University of Michigan, where he graduated with distinction.

Areas of Expertise

• Pharmaceutical and home healthcare industry expertise

• Strategic planning and business development

• Operational excellence and process optimization

• Financial management and performance improvement

• Regulatory compliance and risk management

• Innovative patient-centric care delivery models

Professional Impact
Under Friedman's leadership, BioScrip has achieved significant milestones, including the successful integration of recent acquisitions, the launch of new specialty infusion and pharmacy services, and the implementation of advanced data analytics to enhance patient care and operational efficiency. Friedman's commitment to innovation and his focus on delivering high-quality, personalized care have positioned BioScrip as a leader in the home healthcare and infusion services space.

Conclusion
With his extensive experience, strategic vision, and proven track record of success, Richard Friedman continues to drive BioScrip's growth and expansion, while fostering a culture of excellence and patient-centered care. His leadership and industry expertise make him a valuable asset in the evolving healthcare landscape.